Medical Oncology and Tumor Pharmacotherapy, 0736-0118

Tidskrift

Fler filtreringsmöjligheter
  1. 2020
  2. The issues with tissues: the wide range of cell fate separation enables the evolution of multicellularity and cancer

    Emma U. Hammarlund, Sarah R. Amend & Kenneth J. Pienta, 2020, I : Medical Oncology. 37, 7, 62.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. 2015
  4. Expression of caspase-3 predicts prognosis in advanced noncardia gastric cancer

    Sousana Amptoulach, Andreas C. Lazaris, Ioanna Giannopoulou, Nikolaos Kavantzas, Efstratios Patsouris & Nikolaos Tsavaris, 2015, I : Medical Oncology. 32, 1, s. 416

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. Satisfactory outcome after intensive chemotherapy with pragmatic use of minimal residual disease (MRD) monitoring in older patients with Philadelphia-negative B cell precursor acute lymphoblastic leukaemia: a Swedish registry-based study

    Emma Bergfelt, Piotr Kozlowski, Lucia Ahlberg, Erik Hulegardh, Hans Hagglund, Karin Karlsson, Alicja Markuszewska-Kuczymska, Beata Tomaszewska-Toporska, Bengt Smedmyr, Maria Astrom, Rose-Marie Amini & Helene Hallbook, 2015, I : Medical Oncology. 32, 4, s. 135

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. 2014
  7. Outcome after HSCT in Philadelphia chromosome positive acute lymphoblastic leukemia in Sweden: a population-based study

    E. Hulegardh, H. Hagglund, L. Ahlberg, Karin Karlsson, H. Karbach, A. Markuszewska, I. Persson, M. Astrom & H. Hallbook, 2014, I : Medical Oncology. 31, 8, s. 66

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. 2013
  9. High incidence of chronic graft-versus-host disease after myeloablative allogeneic stem cell transplantation for chronic lymphocytic leukemia in Sweden: graft-versus-leukemia effect protects against relapse

    Maciej Machaczka, Jan-Erik Johansson, Mats Remberger, Helene Hallböök, Vladimir Lj Lazarevic, Björn Engelbrekt Wahlin, Hamdy Omar, Anders Wahlin, Gunnar Juliusson, Eva Kimby & Hans Hägglund, 2013 dec, I : Medical Oncology. 30, 4, s. 762

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. Deregulation of protein phosphatase expression in acute myeloid leukemia

    Nuzhat N. Kabir, Lars Rönnstrand & Julhash U. Kazi, 2013, I : Medical Oncology. 30, 2

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. Enhanced SOX10 and KIT expression in cutaneous melanoma.

    Lars Rönnstrand & Bengt Phung, 2013, I : Medical Oncology. 30, 3, s. 648

    Forskningsoutput: TidskriftsbidragLetter

  12. FLT3 mutations in patients with childhood acute lymphoblastic leukemia (ALL)

    Nuzhat N. Kabir, Lars Rönnstrand & Julhash U. Kazi, 2013, I : Medical Oncology. 30, 1, s. 462-462

    Forskningsoutput: TidskriftsbidragLetter

  13. Impact of the first tumor response at eight weeks on overall survival in metastatic breast cancer patients treated with first-line combination chemotherapy

    Chikako Suzuki, Lennart Blomqvist, Thomas Hatschek, Lena Carlsson, Zakaria Einbeigi, Barbro Linderholm, Birgitta Lindh, Niklas Loman, Martin Malmberg, Samuel Rotstein, Martin Söderberg, Marie Sundqvist, Thomas M. Walz, Gunnar Astrom, Hirofumi Fujii, Hans Jacobsson & Bengt Glimelius, 2013, I : Medical Oncology. 30, 1, s. 415

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. Killing of CLL and NHL cells by rituximab and ofatumumab under limited availability of complement.

    Marcin Okroj, Ingrid Eriksson, Anders Osterborg & Anna Blom, 2013, I : Medical Oncology. 30, 4, s. 759

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. Protein kinase C (PKC) as a drug target in chronic lymphocytic leukemia.

    Julhash U. Kazi, Nuzhat N Kabir & Lars Rönnstrand, 2013, I : Medical Oncology. 30, 4, s. 757

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  16. The basic helix-loop-helix (bHLH) proteins in breast cancer progression

    Nuzhat N. Kabir, Lars Rönnstrand & Julhash U. Kazi, 2013, I : Medical Oncology. 30, 3

    Forskningsoutput: TidskriftsbidragLetter

  17. The impact of hyperfractionated radiotherapy regimen in patients with non-small cell lung cancer

    Georg Holgersson, Michael Bergqvist, Jan Nyman, Even Hoye, Martin Helsing, Signe Friesland, Margareta Holgersson, Lars Ekberg, Charlotte Morth, Simon Ekman, Thomas Blystad, Sven-Börje Ewers, Britta Loden, Roger Henriksson & Stefan Bergstrom, 2013, I : Medical Oncology. 30, 1, s. 320

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. 2012
  19. Swedish lung cancer radiation study group: the prognostic value of anaemia, thrombocytosis and leukocytosis at time of diagnosis in patients with non-small cell lung cancer

    Georg Holgersson, Martin Sandelin, Even Hoye, Stefan Bergstrom, Roger Henriksson, Simon Ekman, Jan Nyman, Martin Helsing, Signe Friesland, Margareta Holgersson, Kristina Lamberg Lundstrom, Christer Janson, Elisabet Birath, Charlotte Morth, Thomas Blystad, Sven-Börje Ewers, Britta Loden & Michael Bergqvist, 2012, I : Medical Oncology. 29, 5, s. 3176-3182

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. 2011
  21. Health-related quality of life after chemotherapy cycle in breast cancer in Iran

    Peivand Bastani & Aliasghar Ahmad Kiadaliri, 2011, I : Medical Oncology. 28, S1, s. S70-S74

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. 2007
  23. Erythropoietin therapy and cancer related anaemia: updated Swedish recommendations

    Jane Ahlqvist-Rastad, Maria Albertsson, Jonas Bergh, Gunnar Birgegard, Peter Johansson, Bertil Jonsson, Elisabeth Kjellén, Sven Pahlman, Bjorn Zackrisson & Anders Osterborg, 2007, I : Medical Oncology. 24, 3, s. 267-272

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  24. Phase II studies on docetaxel alone every third week, or weekly in combination with gemcitabine in patients with primary locally advanced, metastatic, or recurrent esophageal cancer

    M. Albertsson, B. Johansson, S. Friesland, Lianna Kadar, H. Letocha, G. Frykholm & G. Wagenius, 2007, I : Medical Oncology. 24, 4, s. 407-412

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. 2006
  26. Impact of growth factors in the regulation of apoptosis in low-risk myelodysplastic syndromes.

    Ramin Tehranchi, 2006, I : Medical Oncology. 23, 1, s. 37-49

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  27. 2001
  28. Health-related quality of life and its potential prognostic implications in patients with aggressive lymphoma: a Nordic Lymphoma Group Trial

    Mats Jerkeman, S Kaasa, M Hjermstad, S Kvaloy & Eva Cavallin-Ståhl, 2001, I : Medical Oncology. 18, 1, s. 85-94

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. 1999
  30. Hepatosplenic candidiasis after neutropenic phase of acute leukaemia

    M Colović, VLADIMIR LAZAREVIC, R Colović, G Janković, N Suvajdzić, A Bogdanović & J Bila, 1999 jul, I : Medical Oncology. 16, 2, s. 139-42 4 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  31. 1997
  32. Acute megakaryoblastic leukaemia in a patient with systemic lupus erythematosus

    M Colović, G Janković, VLADIMIR LAZAREVIC & A Novak, 1997 mar, I : Medical Oncology. 14, 1, s. 31-4 4 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  33. 1996
  34. Burkitt-like blast crisis in chronic myeloid leukemia

    M Colovic, G Jankovic & VLADIMIR LAZAREVIC, 1996 jun, I : Medical Oncology. 13, 2, s. 119-120

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  35. 1990
  36. 1986